Rosenberg Ellen's Form 4 filing
Amicus Therapeutics, Inc. (FOLD) · filed Nov 26, 2025
- Accession no.
- 0001193125-25-301017
- Filed
- Nov 26, 2025
- Trade date
- Nov 24-26, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 4 derivative transactions. Open-market sales total $958.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rosenberg EllenCIK 0001666380 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | Common Stock | MOption exerciseAcquired | +25,000 | $6.10 | +$152,500 | 532,710 | Direct | |
| Nov 24, 2025 | Common Stock | MOption exerciseAcquired | +11,000 | $5.13 | +$56,430 | 543,710 | Direct | |
| Nov 24, 2025 | Common Stock | SSaleDisposed | −36,000 | $10.06F1 | −$362,160 | 507,710 | Direct | |
| Nov 25, 2025 | Common Stock | MOption exerciseAcquired | +36,000 | $5.13 | +$184,680 | 543,710 | Direct | |
| Nov 25, 2025 | Common Stock | SSaleDisposed | −36,000 | $10.00 | −$360,000 | 507,710 | Direct | |
| Nov 26, 2025 | Common Stock | MOption exerciseAcquired | +23,621 | $5.13 | +$121,175.73 | 531,331 | Direct | |
| Nov 26, 2025 | Common Stock | SSaleDisposed | −23,621 | $10.00 | −$236,210 | 507,710 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | Common Stock | MOption exerciseDisposed | −25,000 | $0.00 | $0 | 0 | Direct | |
| Nov 24, 2025 | Common Stock | MOption exerciseDisposed | −11,000 | $0.00 | $0 | 59,621 | Direct | |
| Nov 25, 2025 | Common Stock | MOption exerciseDisposed | −36,000 | $0.00 | $0 | 23,621 | Direct | |
| Nov 26, 2025 | Common Stock | MOption exerciseDisposed | −23,621 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.00 to $10.31 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Remarks
All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2024.